Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4591950012 | Faropenem sodium | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4591951011 | Faropenem sodium (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4591952016 | Fropenem sodium | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Faropenem sodium | Is a | Substance with beta-lactam structure and antibacterial mechanism of action (substance) | true | Inferred relationship | Some | ||
Faropenem sodium | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | Antibacterial (disposition) | true | Inferred relationship | Some | ||
Faropenem sodium | This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. | Faropenem | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely faropenem (as faropenem sodium) 200 milligram/1 each conventional release oral tablet (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | True | Faropenem sodium | Inferred relationship | Some | 1 |
Reference Sets